Literature DB >> 8178561

Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide-ovalbumin conjugate.

F B Gilbert1, B Poutrel, L Sutra.   

Abstract

Six dairy cows were immunized subcutaneously with purified type 5 capsular polysaccharide (CP5) of Staphylococcus aureus or CP5-ovalbumin conjugate in Freund's incomplete adjuvant. The CP5 antibodies elicited were measured in sera and analysed with regard to isotypes by enzyme-linked immunosorbent assay. At the doses tested, the purified CP5 did not induce a humoral response in the cows. Immunization of two cows with the CP5-ovalbumin conjugate elicited a CP5 antibody response mainly of the IgG2 isotype, which culminated 4 weeks later. A second injection of conjugate, 3 months after the first one, resulted in a rapid and durable anti-CP5 response without exceeding the first antibody peak value. Intramammary infusion of purified CP5 failed to provoke an inflammatory response in the milk of the immunized cows. In contrast, a marked recruitment of cells was recorded in the milk of the sensitized cows after intramammary infusion of ovalbumin. These results demonstrate that injection of CP5-protein carrier conjugate in cows entails both antibody response against CP5 and carrier-specific recruitment of cells in milk of immunized animals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8178561     DOI: 10.1016/0264-410x(94)90103-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Protein antigens increase the protective efficacy of a capsule-based vaccine against Staphylococcus aureus in a rat model of osteomyelitis.

Authors:  Santiago M Lattar; Mariángeles Noto Llana; Philippe Denoël; Sophie Germain; Fernanda R Buzzola; Jean C Lee; Daniel O Sordelli
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

2.  Heterogeneity of cell-associated CP5 expression on Staphylococcus aureus strains demonstrated by flow cytometry.

Authors:  B Poutrel; P Rainard; P Sarradin
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

3.  Staphylococcus aureus capsular polysaccharide types 5 and 8 reduce killing by bovine neutrophils in vitro.

Authors:  Annette H Kampen; Tore Tollersrud; Arve Lund
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

4.  Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis.

Authors:  Jai-Wei Lee; Celia N O'Brien; Albert J Guidry; Max J Paape; Kimberley A Shafer-Weaver; X Zhao
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

Review 5.  Staphylococcus aureus capsular polysaccharides.

Authors:  Katherine O'Riordan; Jean C Lee
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

6.  Antibodies to capsular polysaccharides are not protective against experimental Staphylococcus aureus endocarditis.

Authors:  J Nemeth; J C Lee
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

7.  Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.

Authors:  Guillaume Goyette-Desjardins; Cynthia Calzas; Tze Chieh Shiao; Axel Neubauer; Jennifer Kempker; René Roy; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2016-06-23       Impact factor: 3.441

8.  Antibody responses in sheep vaccinated against Staphylococcus aureus mastitis: a comparison of two experimental vaccines containing different adjuvants.

Authors:  T Tollersrud; P E Nørstebø; J P Engvik; S R Andersen; L J Reitan; A Lund
Journal:  Vet Res Commun       Date:  2002-12       Impact factor: 2.459

9.  Immunization routes in cattle impact the levels and neutralizing capacity of antibodies induced against S. aureus immune evasion proteins.

Authors:  Eveline Boerhout; Manouk Vrieling; Lindert Benedictus; Ineke Daemen; Lars Ravesloot; Victor Rutten; Piet Nuijten; Jos van Strijp; Ad Koets; Susanne Eisenberg
Journal:  Vet Res       Date:  2015-09-28       Impact factor: 3.683

Review 10.  Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses.

Authors:  Sharmeen Nishat; Peter R Andreana
Journal:  Vaccines (Basel)       Date:  2016-05-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.